Kymera Therapeutics, Inc. (KYMR) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$311.35M | -39.1% |
| 2024 | -$223.86M | -52.3% |
| 2023 | -$146.96M | +5.1% |
| 2022 | -$154.81M | -54.5% |
| 2021 | -$100.22M | -119.8% |
| 2020 | -$45.59M | -10.5% |
| 2019 | -$41.25M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$311.35M | -39.1% |
| 2024 | -$223.86M | -52.3% |
| 2023 | -$146.96M | +5.1% |
| 2022 | -$154.81M | -54.5% |
| 2021 | -$100.22M | -119.8% |
| 2020 | -$45.59M | -10.5% |
| 2019 | -$41.25M | — |